Patients Stopping Anti-Obesity Injections Regain Weight Far More Rapidly Than People Using Diet and Exercise

Fresh analysis reveals that patients who come off blockbuster slimming jabs like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle programs.

Published data in a prominent health publication points out that while overweight individuals can lose substantial amounts of their body weight while using the jabs, the mass is regained at an average rate of 0.8 kg per month after stopping.

"Users purchasing such treatments must be informed of the risk of fast rebound weight gain when the treatment concludes," warns expert Dr. Susan Jebb.

Such speed of recovery implies a reversion to starting mass within about a year and a half.

Analyzing Therapies

The study, which examined 37 of studies involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with other pills.

Researchers emphasize that individuals who lose weight through dieting usually have a more gradual weight regain—approximately 100 grams monthly—post-intervention.

Understanding the Fast Regain

Doctors suggest the mode of action of the injections explains the accelerated rebound.

The injections copy a natural hormone called GLP-1, which controls hunger.

"Sustained high doses of the hormone concentrations far above than the body's typical production could lead to the body to produce less of its endogenous hormone, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making overeating much more probable."

An Ongoing Disease?

Health authorities recommend the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals argue that, due to the significant potential of relapse, the therapy is often long-term.

This opinion is supported by drug manufacturers, who state that the results "underscore the chronic character of excess weight," comparing it to managing conditions like high blood pressure.

User Accounts

Users who have discontinued the jabs describe a powerful resurgence of cravings.

"I experienced a switch flipping and you're instantly ravenous," said one woman.

This challenge is exacerbated if users have not adopted permanent lifestyle or habit modifications during treatment.

Widespread Interest

Figures indicate that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.

• Adoption is greater among women compared to men.
• The 40s and 50s demographic shows the greatest usage rates.
• Many access the drugs through private prescriptions rather than public health services.

In conclusion, experts stress that while GLP-1 drugs are powerful agents for weight loss, they are not a standalone cure and long-term success likely depends on combined lifestyle changes.